enGene (ENGN) Holdings announced that it has commenced an underwritten public offering of its common shares. All common shares to be sold in the offering will be offered by enGene. Jefferies, Leerink Partners and Wells Fargo Securities are acting as joint book running managers for the proposed offering.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENGN:
- enGene price target raised to $19 from $18 at Morgan Stanley
- enGene price target raised to $33 from $30 at Oppenheimer
- enGene price target raised to $10 from $4 at UBS
- Cautious Hold Rating for enGene Holdings Amid Competitive Trial Results and Market Uncertainty
- enGene price target raised to $21 from $18 at Citizens JMP